Axim Biotechnologies, Inc.
AXIM· OTC
AXIMAxim Biotechnologies, Inc.
Filed Apr 15, 2021 · 10-K · 105 days after period end · 0001078782-21-000365
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures |
|---|---|---|---|---|
| Revenue | $0.00 | $782.42K | $166.97K | $15.46K |
| Net Income | -$2.40M | -$1.44M | -$978.89K | -$1.44M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Axim Biotechnologies, Inc. · CIK 1514946 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Apr 15, 2021 · 105 d after period end
